Peer-influenced content. Sources you trust. No registration required. This is HCN.
Multiple Sclerosis News Today
Gadoquatrane, a promising GBCA, enters Phase 3 clinical testing, potentially offering safer MRI procedures and advancing diagnostic capabilities for patients with CNS disorders, including MS.
Neurology July 11th 2023
MDLinx
The surprising association between CHIP and a lowered risk of Alzheimer’s disease offers a novel perspective in our understanding of neurodegenerative disorders and paves the way for potential future therapeutics.
Hematology July 11th 2023
British Medical Journal
Emerging research uncovers potential associations between the use of menopausal hormone therapy and an increased risk of dementia, including Alzheimer’s disease. Discover more about the implications of these findings for women’s health management.
Parkinson’s News Today
Explore the new era of Parkinson’s disease treatment with the Cala kIQ System, a wearable, FDA-approved device designed to control action tremors by emulating the principles of deep brain stimulation.
Neurology July 6th 2023
Explore how thought control has been utilized in groundbreaking technology to enable a paralyzed man to walk naturally again, unveiling a new frontier in neuroscience and potentially revolutionizing paralysis treatment.
ReachMD
Discover how prucalopride, typically used as a laxative, is showing promise as a cognitive enhancer in recent neurological research. Learn more about its potential implications for treating cognitive deficits in mood disorders.
Neurology July 5th 2023